Hyloris Pharmaceuticals SA stock forecast
Hyloris Pharmaceuticals SA (52U) Stock Forecast & Price Target
52U Analyst Ratings
52U Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Christophe dombu | Kepler Capital | €14.30 | buy | 243.75%Upside | Reiterated | 03/26/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Christophe dombuKepler Capital | BuyReiterated€14.30 | 03/26/26 | 243.75%Upside |
Best Analysts Covering Hyloris Pharmaceuticals SA
Copying Christophe dombu's trades and holding each position for 3 Months would result in 43.75% of your transactions generating a profit, with an average return of -0.61% per trade.
Copying Christophe dombu's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -18.26% per trade.
Copying Christophe dombu's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -41.33% per trade.
52U Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, 52U has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 52U average Analyst price target in the past 3 months is ―.
52U Financial Forecast
52U Earnings Forecast
Next quarter’s earnings estimate for 52U is -EUR 0.07 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.07. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
52U Sales Forecast
Next quarter’s sales forecast for 52U is EUR 4.70M with a range of ― to ―. The previous quarter’s sales results were EUR 4.70M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
